This level of precision is overkill for standard dosing but invaluable for microdosing protocols where researchers work with doses of 0.25 mg to 1 mg
AOD 9604 rewards consistency
Technical Specifications Compound: BPC-157 (Synthetic Pentadecapeptide) Format: Lyophilized peptide powder Strength: 10 mg per vial Purity: 9899% (COA included) Appearance: White lyophilized powder Category: Research peptide reagent Intended Use This product is intended strictly for: Laboratory experimentation In-vitro scientific research Biochemical and molecular studies Non-human preclinical model development Institutional or academic research programs Not intended for: Human or animal consumption Injection, ingestion, inhalation, or topical use Medical, therapeutic, diagnostic, or cosmetic purposes This compound is not approved by Health Canada, FDA, or any regulatory authority for clinical use
PLEASE NOTE: Even though initial research has demonstrated promising results, it is important to note that further clinical studies are needed to fully understand the safety, efficacy, and recommended dosage for BPC 157
Frequency: Once or twice per day (subcutaneous)
In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms
